The Patent Finder

Avalyn Pharma Inc.

14 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Genoa Pharmaceuticals, Inc. (to 2017)

Previously recorded as Windward Pharma, Inc. (to 2020)

0
Ending by 2030
Jan 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 7, 2027
    The maintenance fee for Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof (US 10,610,536) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
  • 1 fee due Nov 14, 2027
    The maintenance fee for Inhaled Imatinib for Treatment of Pulmonary Arterial Hypertension (PAH) (US 11,980,689) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,224,592Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,452,718Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 11,559,520Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 12,226,407Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 10,092,552Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,105,356Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,980,689Inhaled Imatinib for Treatment of Pulmonary Arterial Hypertension (PAH)
In force
 · Medium confidence
In forceMedium confidence
US 9,770,443Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,028,966Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,610,536Aerosol Pirfenidone and Pyridone Analog Compounds and Uses Thereof
In force
 · High confidence
In forceHigh confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 2 abandoned · 1 no status recorded

Showing 1 to 10 of 12, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
19/014,801Aerosol Pirfenidone and Pyridone Analog Compounds and Uses ThereofJan 9, 2025Pending
18/974,588Nintedanib and Nintedanib Combination Dry Powder Compositions and UsesDec 9, 2024Pending
18/961,095Nintedanib and Nintedanib Combination Dry Powder Compositions and UsesNov 26, 2024Pending
18/887,514Specially Formulated Compositions of Inhaled Nintedanib and Nintedanib SaltsSep 17, 2024Pending
18/664,718Aerosol Pirfenidone and Pyridone Analog Compounds and Uses ThereofMay 15, 2024Pending
18/662,936Inhaled Imatinib for Treatment of Pulmonary Arterial Hypertension (PAH)May 13, 2024Abandoned
18/171,930Nebulizer Device Optimization for Improved Aerosol Parameters and Uses ThereofFeb 21, 2023Pending
17/576,830Aerosol Pirfenidone and Pyridone Analog Compounds and Uses ThereofJan 14, 2022Pending
17/542,262Aerosol Tyrosine Kinase Inhibitor Compounds and Uses ThereofDec 3, 2021Pending
18/042,375Nebulizer Device Optimization for Improved Aerosol Parameters and Uses ThereofSep 22, 2021Pending
10 of 12 applications shown.
Pro members see all 12 published applications.
Pro members: see all 12 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited